From early days with its distinct morphology, to more recent description of the almost universal expression of BRAF mutations and their contribution to pathogenesis of the disease, HCL has been recognized as a relatively uncommon hematological neoplasm with distinct biological features [8, 9]. Here, BRAF is linked to hairy cell leukemia.